Home/Filings/4/0001415889-23-014485
4//SEC Filing

Bergmann Anthony 4

Accession 0001415889-23-014485

CIK 0001133869other

Filed

Oct 23, 8:00 PM ET

Accepted

Oct 24, 9:25 AM ET

Size

7.4 KB

Accession

0001415889-23-014485

Insider Transaction Report

Form 4
Period: 2023-10-23
Bergmann Anthony
CHIEF FINANCIAL OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2023-10-23$1.39/sh+2,178$3,0272,381 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-10-232,1780 total
    Exercise: $1.39Exp: 2023-10-23Common Stock (2,178 underlying)
Footnotes (2)
  • [F1]This option was granted on October 23, 2013 and was previously reported as covering 21,785 shares at an exercise price of $0.30 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
  • [F2]The shares vested annually over a 4 year period commencing on November 1, 2014.

Issuer

CAPRICOR THERAPEUTICS, INC.

CIK 0001133869

Entity typeother

Related Parties

1
  • filerCIK 0001593087

Filing Metadata

Form type
4
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 9:25 AM ET
Size
7.4 KB